Financial Results for Quarter Ended June 30, 2026

The Board approved the unaudited standalone financial results for the quarter ended June 30, 2026:

Income Statement (₹ in lakhs):

  • Revenue from Operations: ₹850.02
  • Other Income: ₹11.44
  • Total Income: ₹870.46
  • Total Expenses: ₹871.98
  • Loss Before Tax: ₹(1.52)
  • Tax Expense: ₹(1.80) [Deferred Tax]
  • Net Profit After Tax: ₹0.28
  • Total Comprehensive Income for the period: ₹(1.49)

Capital Structure:

  • Paid-up Equity Share Capital: ₹746.89 lakhs (Face value ₹10 per share)
  • Reserves (excluding Revaluation Reserve): ₹1054.43 lakhs

Per Share Data:

  • Basic EPS: ₹0.00
  • Diluted EPS: ₹0.00

Comparative Figures:

  • Quarter Ended March 31, 2026: Net Loss of ₹(2.13) lakhs
  • Year Ended March 31, 2026: Net Loss of ₹(111.72) lakhs

Management Appointments

The Board approved the following appointments based on the recommendation of the Nomination and Remuneration Committee:

1. Dr. Thanigai Vendan Moorrthy (PAN: ADUPTO0825B) as Chief Executive Officer (Non-Director Capacity) and Key Managerial Personnel, effective August 11, 2026, for a 5-year term. Profile: Senior Anesthesiologist and healthcare executive with 15+ years of clinical and leadership experience.

2. Mr. A F Simeon Telfer (DIN: 11879121) as Additional Non-Executive Independent Director, effective August 11, 2026, for a 5-year term, subject to shareholder approval at the ensuing AGM. Profile: Seasoned professional and entrepreneur with experience in business development and strategic planning.

3. Mr. R V Ramanuja Bharathi (DIN: 08553270) as Additional Non-Executive Independent Director, effective August 11, 2026, for a 5-year term, subject to shareholder approval at the ensuing AGM. Profile: Distinguished advocate with extensive experience in legal strategy and corporate law.

4. Ms. Sindu Chawla (DIN: 11879201) as Additional Non-Executive Independent Director, effective August 11, 2026, for a 5-year term, subject to shareholder approval at the ensuing AGM. Profile: Software engineering leader with 15+ years of experience in computer networking and protocol development.

All appointees confirmed they are not related to any existing directors/KMPs and are not debarred from holding director office.

Committee Reconstitution

Following the new director appointments, the Board reconstituted committees effective August 11, 2026:

Audit Committee:

  • Mr. M. Karunakaran (Independent Director) - Chairman
  • Mr. A F Simeon Telfer (Independent Director) - Member
  • Mrs. Jayanthi Radhakrishnan (Executive Director) - Member

Stakeholders Relationship Committee:

  • Ms. Sindu Chawla (Independent Director) - Chairman
  • Mr. R V Ramanuja Bharathi (Independent Director) - Member
  • Mr. Edward Prabhakar (Non-Executive Director) - Member

Additional Information

The company operates in a single segment: Hospital. Figures for previous periods have been regrouped/reclassified where necessary. The quarter ended March 31, 2026 figures are balancing figures between audited annual figures and published unaudited nine-month figures.